Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Showcase News Releases

Showcase news

Regenx Tech Corp.
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order
Bocana Resources Corp.
Bocana Resources Corp. Announces Grant of Stock Options
Nextech3D.ai
Nextech3D.ai Reports Q1 2024 Revenue of $1,024,000 with Gross Profit Margin of 51% or $526,212 A +70% Jump Over 2023

More Showcase News Releases »